• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与结直肠癌发生和预后相关的可变剪接事件。

Alternative splicing events implicated in carcinogenesis and prognosis of colorectal cancer.

作者信息

Liu Jingwei, Li Hao, Shen Shixuan, Sun Liping, Yuan Yuan, Xing Chengzhong

机构信息

Tumor Etiology and Screening Department of Cancer Institute and General Surgery, the First Hospital of China Medical University, and Key Laboratory of Cancer Etiology and Prevention (China Medical University), Liaoning Provincial Education Department, Shenyang 110001, China.

出版信息

J Cancer. 2018 Apr 19;9(10):1754-1764. doi: 10.7150/jca.24569. eCollection 2018.

DOI:10.7150/jca.24569
PMID:29805701
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5968763/
Abstract

Emerging evidence suggested that aberrant alternative splicing (AS) is pervasive event in development and progression of cancer. However, the information of aberrant splicing events involved in colorectal carcinogenesis and progression is still elusive. In this study, splicing data of 499 colon adenocarcinoma cases (COAD) and 176 rectum adenocarcinoma (READ) with clinicopathological information were obtained from The Cancer Genome Atlas (TCGA) to explore the changes of alternative splicing events in relation to the carcinogenesis and prognosis of colorectal cancer (CRC). Gene interaction network construction, functional and pathway enrichment analysis were performed by multiple bioinformatics tools. Overall, most AS patterns were more active in CRC tissues than adjacent normal ones. We detected altogether 35391 AS events of 9084 genes in COAD and 34900 AS events of 9032 genes in READ, some of which were differentially spliced between cancer tissues and normal tissues including genes of SULT1A2, CALD1, DTNA, COL12A1 and TTLL12. Differentially spliced genes were enriched in biological process including muscle organ development, cytoskeleton organization, actin cytoskeleton organization, biological adhesion, and cell adhesion. The integrated predictor model of COAD showed an AUC of 0.805 (sensitivity: 0.734; specificity: 0.756) while READ predictor had an AUC of 0.738 (sensitivity: 0.614; specificity: 0.900). In addition, a number of prognosis-associated AS events were discovered, including genes of PSMD2, NOL8, ALDH4A1, SLC10A7 and PPAT. We draw comprehensive profiles of alternative splicing events in the carcinogenesis and prognosis of CRC. The interaction network and functional connections were constructed to elucidate the underlying mechanisms of alternative splicing in CRC.

摘要

新出现的证据表明,异常可变剪接(AS)是癌症发生和发展过程中普遍存在的事件。然而,结直肠癌发生和发展过程中涉及的异常剪接事件的信息仍然难以捉摸。在本研究中,从癌症基因组图谱(TCGA)获取了499例结肠腺癌(COAD)和176例直肠腺癌(READ)的剪接数据以及临床病理信息,以探讨可变剪接事件与结直肠癌(CRC)发生及预后的关系。使用多种生物信息学工具进行基因相互作用网络构建、功能和通路富集分析。总体而言,大多数AS模式在CRC组织中比相邻正常组织更活跃。我们在COAD中总共检测到9084个基因的35391个AS事件,在READ中检测到9032个基因的34900个AS事件,其中一些在癌组织和正常组织之间存在差异剪接,包括SULT1A2、CALD1、DTNA、COL12A1和TTLL12等基因。差异剪接基因富集于生物学过程,包括肌肉器官发育、细胞骨架组织、肌动蛋白细胞骨架组织、生物黏附以及细胞黏附。COAD的综合预测模型的AUC为0.805(敏感性:0.734;特异性:0.756),而READ预测模型的AUC为0.738(敏感性:0.614;特异性:0.900)。此外,还发现了一些与预后相关的AS事件,包括PSMD2、NOL8、ALDH4A1、SLC10A7和PPAT等基因。我们绘制了CRC发生和预后过程中可变剪接事件的综合图谱。构建了相互作用网络和功能连接,以阐明CRC中可变剪接的潜在机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faeb/5968763/a8f1d9e66d11/jcav09p1754g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faeb/5968763/f759d5ddac09/jcav09p1754g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faeb/5968763/690c70d1f8ce/jcav09p1754g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faeb/5968763/37bf60d30d24/jcav09p1754g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faeb/5968763/36df8505160f/jcav09p1754g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faeb/5968763/9fc2a67471f1/jcav09p1754g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faeb/5968763/a8f1d9e66d11/jcav09p1754g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faeb/5968763/f759d5ddac09/jcav09p1754g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faeb/5968763/690c70d1f8ce/jcav09p1754g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faeb/5968763/37bf60d30d24/jcav09p1754g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faeb/5968763/36df8505160f/jcav09p1754g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faeb/5968763/9fc2a67471f1/jcav09p1754g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faeb/5968763/a8f1d9e66d11/jcav09p1754g008.jpg

相似文献

1
Alternative splicing events implicated in carcinogenesis and prognosis of colorectal cancer.与结直肠癌发生和预后相关的可变剪接事件。
J Cancer. 2018 Apr 19;9(10):1754-1764. doi: 10.7150/jca.24569. eCollection 2018.
2
Profiles of alternative splicing in colorectal cancer and their clinical significance: A study based on large-scale sequencing data.结直肠癌中可变剪接的特征及其临床意义:基于大规模测序数据的研究。
EBioMedicine. 2018 Oct;36:183-195. doi: 10.1016/j.ebiom.2018.09.021. Epub 2018 Sep 19.
3
Genome-Wide Profiling of Prognostic Alternative Splicing Signature in Colorectal Cancer.结直肠癌预后性可变剪接特征的全基因组分析
Front Oncol. 2018 Nov 20;8:537. doi: 10.3389/fonc.2018.00537. eCollection 2018.
4
The early predictive effect of low expression of the in colorectal cancer.其在结直肠癌中低表达的早期预测作用。 (你提供的原文中“the ”后面缺少具体内容,我按照字面意思翻译了,如果有遗漏信息请补充完整以便更准确翻译)
J Gastrointest Oncol. 2022 Feb;13(1):265-278. doi: 10.21037/jgo-22-92.
5
Comprehensive investigation of alternative splicing and development of a prognostic risk score for prostate cancer based on six-gene signatures.基于六个基因特征的前列腺癌可变剪接综合研究及预后风险评分的开发。
J Cancer. 2019 Sep 7;10(22):5585-5596. doi: 10.7150/jca.31725. eCollection 2019.
6
Comprehensive characterization of the alternative splicing landscape in head and neck squamous cell carcinoma reveals novel events associated with tumorigenesis and the immune microenvironment.全面描绘头颈部鳞状细胞癌中的可变剪接全景,揭示与肿瘤发生和免疫微环境相关的新事件。
Theranostics. 2019 Oct 14;9(25):7648-7665. doi: 10.7150/thno.36585. eCollection 2019.
7
Construction of prognostic predictor by comprehensive analyzing alternative splicing events for colon adenocarcinoma.通过综合分析结肠腺癌的可变剪接事件构建预后预测模型
World J Surg Oncol. 2020 Sep 3;18(1):236. doi: 10.1186/s12957-020-02010-7.
8
Analysis of SLC genes alternative splicing identifies the SLC7A6 RI isoform as a therapeutic target for colorectal cancer.对溶质载体(SLC)基因可变剪接的分析确定溶质载体家族7成员6(SLC7A6)RI亚型为结直肠癌的治疗靶点。
Cancer Sci. 2025 Jan;116(1):233-247. doi: 10.1111/cas.16351. Epub 2024 Oct 15.
9
Long-read sequencing reveals the landscape of aberrant alternative splicing and novel therapeutic target in colorectal cancer.长读测序揭示了结直肠癌中异常可变剪接的全景和新的治疗靶点。
Genome Med. 2023 Sep 21;15(1):76. doi: 10.1186/s13073-023-01226-y.
10
Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases.基于317例样本的剪接序列数据构建膀胱尿路上皮癌可变剪接事件的预后特征
Cell Physiol Biochem. 2018;48(3):1355-1368. doi: 10.1159/000492094. Epub 2018 Jul 26.

引用本文的文献

1
From colon wall to tumor niche: Unraveling the microbiome's role in colorectal cancer progression.从结肠壁到肿瘤微环境:解析微生物组在结直肠癌进展中的作用。
PLoS One. 2024 Oct 22;19(10):e0311233. doi: 10.1371/journal.pone.0311233. eCollection 2024.
2
Mapping alternative splicing events in colorectal cancer.绘制结直肠癌中的可变剪接事件图谱。
Discov Oncol. 2024 Jul 15;15(1):280. doi: 10.1007/s12672-024-01149-z.
3
Azoxymethane-induced carcinogenesis-like model of mouse intestine and mouse embryonic stem cell-derived intestinal organoids.

本文引用的文献

1
SRSF6-regulated alternative splicing that promotes tumour progression offers a therapy target for colorectal cancer.SRSF6 调控的可变剪接促进肿瘤进展,为结直肠癌提供了治疗靶点。
Gut. 2019 Jan;68(1):118-129. doi: 10.1136/gutjnl-2017-314983. Epub 2017 Nov 7.
2
Commentary: HNRNPLL, a newly identified colorectal cancer metastasis suppressor, modulates alternative splicing of during epithelial-mesenchymal transition.评论:HNRNPLL,一种新发现的结直肠癌转移抑制因子,在上皮-间质转化过程中调节……的可变剪接。 (原文此处“of”后面内容缺失)
Front Cell Dev Biol. 2017 Oct 16;5:91. doi: 10.3389/fcell.2017.00091. eCollection 2017.
3
氧化偶氮甲烷诱导的小鼠肠道癌变模型和小鼠胚胎干细胞来源的肠道类器官。
Mol Biol Rep. 2024 Jun 1;51(1):704. doi: 10.1007/s11033-024-09660-w.
4
A panel based on three-miRNAs as diagnostic biomarker for prostate cancer.基于三种微小RNA的前列腺癌诊断生物标志物组合。
Front Genet. 2024 May 16;15:1371441. doi: 10.3389/fgene.2024.1371441. eCollection 2024.
5
Colorectal cancer: a comprehensive review of carcinogenesis, diagnosis, and novel strategies for classified treatments.结直肠癌:癌变、诊断的全面综述及分类治疗的新策略。
Cancer Metastasis Rev. 2024 Jun;43(2):729-753. doi: 10.1007/s10555-023-10158-3. Epub 2023 Dec 19.
6
Identification of Key Prognostic Alternative Splicing Events of Costimulatory Molecule-Related Genes in Colon Cancer.鉴定结肠癌中与共刺激分子相关基因的关键预后可变剪接事件。
Comb Chem High Throughput Screen. 2024;27(13):1900-1912. doi: 10.2174/0113862073249972231026060301.
7
Comprehensive analysis of alternative splicing across multiple transcriptomic cohorts reveals prognostic signatures in prostate cancer.综合分析多个转录组队列中的可变剪接,揭示前列腺癌的预后特征。
Hum Genomics. 2023 Nov 3;17(1):97. doi: 10.1186/s40246-023-00545-w.
8
NSPA: characterizing the disease association of multiple genetic interactions at single-subject resolution.NSPA:在单个体分辨率下表征多个基因相互作用的疾病关联。
Bioinform Adv. 2023 Feb 7;3(1):vbad010. doi: 10.1093/bioadv/vbad010. eCollection 2023.
9
Positive regulators of T cell functions as predictors of prognosis and microenvironment characteristics of low-grade gliomas.T 细胞功能的正向调节剂可预测低级别神经胶质瘤的预后和微环境特征。
Front Immunol. 2023 Jan 16;13:1089792. doi: 10.3389/fimmu.2022.1089792. eCollection 2022.
10
The Role of Alternative Splicing Factors hnRNP G and Fox-2 in the Progression and Prognosis of Esophageal Cancer.hnRNP G 和 Fox-2 等剪接因子在食管癌进展和预后中的作用。
Dis Markers. 2022 Nov 23;2022:3043737. doi: 10.1155/2022/3043737. eCollection 2022.
Alternative splicing in cancers: From aberrant regulation to new therapeutics.
癌症中的可变剪接:从异常调控到新的治疗策略。
Semin Cell Dev Biol. 2018 Mar;75:13-22. doi: 10.1016/j.semcdb.2017.09.018. Epub 2017 Sep 14.
4
Selective substrate uptake: The role of ATP-binding cassette (ABC) importers in pathogenesis.选择性底物摄取:ATP 结合盒(ABC)转运蛋白在发病机制中的作用。
Biochim Biophys Acta Biomembr. 2018 Apr;1860(4):868-877. doi: 10.1016/j.bbamem.2017.08.011. Epub 2017 Aug 25.
5
Histone methyltransferase SETD2 modulates alternative splicing to inhibit intestinal tumorigenesis.组蛋白甲基转移酶SETD2调节可变剪接以抑制肠道肿瘤发生。
J Clin Invest. 2017 Sep 1;127(9):3375-3391. doi: 10.1172/JCI94292. Epub 2017 Aug 21.
6
The role of RNA alternative splicing in regulating cancer metabolism.RNA可变剪接在调节癌症代谢中的作用。
Hum Genet. 2017 Sep;136(9):1113-1127. doi: 10.1007/s00439-017-1803-x. Epub 2017 Apr 20.
7
Multiple Roles of APC and its Therapeutic Implications in Colorectal Cancer.抗原呈递细胞(APC)在结直肠癌中的多重作用及其治疗意义
J Natl Cancer Inst. 2017 Aug 1;109(8). doi: 10.1093/jnci/djw332.
8
RNA splicing and splicing regulator changes in prostate cancer pathology.前列腺癌病理学中的RNA剪接及剪接调节因子变化
Hum Genet. 2017 Sep;136(9):1143-1154. doi: 10.1007/s00439-017-1792-9. Epub 2017 Apr 5.
9
A saga of cancer epigenetics: linking epigenetics to alternative splicing.癌症表观遗传学传奇:将表观遗传学与可变剪接联系起来
Biochem J. 2017 Mar 7;474(6):885-896. doi: 10.1042/BCJ20161047.
10
Pharmacology of Modulators of Alternative Splicing.可变剪接调节剂的药理学
Pharmacol Rev. 2017 Jan;69(1):63-79. doi: 10.1124/pr.115.011239.